41 citations
,
February 2021 in “Cureus” This study found that in males with mild COVID-19, treatment with dutasteride, along with standard therapy, may reduce viral shedding and inflammation compared to placebo.
December 2025 in “Journal of Pharmacy And Bioallied Sciences” In this study, trichoscopy was found to enhance the early assessment of minoxidil therapy in males with pattern hair loss, leading to improved satisfaction and treatment compliance by revealing positive changes visible within one month.
12 citations
,
March 2004 in “International Journal of Dermatology” This case report describes a 16-year-old girl initially diagnosed with chronic telogen effluvium, later reassessed with Ludwig Stage 1 androgenetic alopecia, for which she began spironolactone treatment.
3 citations
,
October 2018 in “Skin appendage disorders” In this study, Spectral DNC-N® significantly reduced hair shedding and increased hair mass and density in women with early female pattern hair loss, with effects evident after 3 months and sustained through 6 months.
January 2025 in “International Journal of Medicine in Developing Countries” This study explored androgenetic alopecia in a large Saudi sample, finding that onset often occurs in youth, with strong family aggregation and minimal use of treatments like minoxidil, despite high rates of hair shedding during combing, especially among women.